Empirical evidence supports the idea that gut microbiota plays a central role in the pathogenesis of AP, influencing inflammation, gut permeability, glycemic control, lipid metabolism, insulin sensitivity, and host energy homeostasis.[8] This study hypothesizes that gut microbiota may modulate the signaling effects of melatonin and consequently impact the severity of AP. Here, INS is linked to alkaline phosphatase measurement.